Preoperative NT-proBNP Levels: A Reliable Parameter to Estimate Postoperative Atrial Fibrillation in Coronary Artery Bypass Patients

Abstract

Background: Atrial fibrillation (AF) is one of the most common complications after coronary artery bypass grafting (CABG). This study was designed to evaluate whether the levels of preoperative and postoperative N-terminal pro-brain natriuretic peptide (NT-proBNP) are predictors of postoperative paroxysmal atrial fibrillation in patients who undergo coronary artery bypass surgery. Methods: A total of 117 patients were prospectively evaluated for new-onset AF after coronary operation. Plasma NT-proBNP values in all patients were measured at five different time points. Results: AF occurred during the hospitalization period in 33 patients (28.2 %). Significantly higher NT-proBNP levels in the preoperative examination were recorded in patients who developed AF postoperatively compared with patients without postoperative AF (329.36 ± 82.93 vs. 230.67 ± 59.93 pg/ml, p < 0.05). Although we detected some higher values in the other group of patients with AF (at T1, T2, T3, T4), the difference was not statistically significant compared to the normal rhythm group. Conclusion: The main finding of the current study is a positive correlation between high levels of preoperative NT-proBNP and the risk of new-onset AF after CABG surgery.

coronary bypass surgery - NT‐proBNP - atrial fibrillation

References

• 1 Tisdale J E, Borzak S, Sabbah H N, Shimoyama H, Goldstein S. Hemodynamic and neurohormonal predictors and consequences of the development of atrial fibrillation in dogs with chronic heart failure.  J Card Fail. 2006;  12 747-751
• 2 Sarzi Braga S, Vaninetti R, Pedretti R F. Plasma B-type natriuretic peptide predicts atrial fibrillation during rehabilitation after cardiac surgery.  Eur J Cardiovasc Prev Rehabil. 2008;  15 (4) 460-466
• 3 Gibson P H, Croal B L, Cuthbertson B H et al. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting.  Am Heart J. 2009;  158 244-251
• 4 Price J, Tee R, Lam B K, Hendry P, Green M S, Rubens F D. Current use of prophylactic strategies for postoperative atrial fibrillation.  Ann Thorac Surg. 2009;  88 106-111
• 5 Sleilaty G, Madi-Jebara S, Yazigi A et al. Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery.  Int J Cardiol. 2009;  137 116-122
• 6 Ahlsson A, Bodin L, Fengsrud E, Englund A. Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality.  Scand Cardiovasc J. 2009;  43 330-336
• 7 van den Berg M P, Tjeerdsma G, Jan de Kam P, Boomsma F, Crijns H J, van Veldhuisen D J. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.  Eur J Heart Fail. 2002;  4 (3) 255-262
• 8 Tavakol M, Hassan K Z, Abdula R K et al. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations.  Ann Thorac Surg. 2009;  88 802-808
• 9 Bold A J, Bruneau B G, Bold M L K. Mechanical and neuroendocrine regulation of the endocrine heart.  Cardiovasc Res. 1996;  31 7-18
• 10 Ferro C R, Oliveira D C, Nunes F P, Piegas L S. Postoperative atrial fibrillation after cardiac surgery.  Arq Bras Cardiol. 2009;  93 (1) 55-59
• 11 Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation.  Ann Thorac Surg. 2009;  88 326-333
• 12 Kalavrouziotis D, Buth K J, Vyas T, Ali I S. Preoperative atrial fibrillation decreases event-free survival following cardiac surgery.  Eur J Cardiothorac Surg. 2009;  36 (2) 293-299
• 13 Jourdain P, Bellorini M, Funk F, Fulla Y, Guillard N, Loiret J et al. Short-term effects of sinus rhythm restoration in patients with lone atrial fibrillation.  Eur J Heart Fail. 2002;  4 263-267
• 14 Cowie M R, Jourdain P, Maisel A et al. Clinical applications of B-type natriuretic peptide (BNP) testing.  Eur Heart J. 2003;  24 (19) 1710-1718
• 15 Watanabe I, Tani S, Nagao K, Anazawa T, Kawamata H. Regulation of arginine vasopressin in the human heart.  Circ J. 2005;  69 1401-1404
• 16 Thejus J, Francis J. N-terminal pro-brain natriuretic peptide and atrial fibrillation.  Indian Pacing Electrophysiol J. 2009;  9 (1) 1-4
• 17 Mustafa Cerrahoglu M, Iskesen I, Tekin C, Onur E, Yildirim F, Sirin B H. N-terminal ProBNP levels can predict cardiac failure after cardiac surgery.  Circ J. 2007;  71 79-83
• 18 Nybo M, Benn M, Mogelvang R et al. Impact of hemoglobin on plasma Pro-B-type natriuretic peptide concentrations in the general population.  Clin Chem. 2007;  53 (11) 1921-1927
• 19 Dini F L, Fontanive P, Buralli S et al. N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I–II systolic heart failure.  Int J Cardiology. 2009;  136 144-150